For the healthy future of our customers - SK biopharmaceuticals Business Division has built a business model encompassing the entire value chain from new drug R&D to marketing on the capabilities and technologies that it accumulated in the field of new drug and pharmaceutical intermediate R&D initiatives
For the healthy future of our customers - SK biopharmaceuticals Business Division has built a business model encompassing the entire value chain from new drug R&D to marketing on the capabilities and technologies that it accumulated in the field of new drug and pharmaceutical intermediate R&D initiatives
For the healthy future of our customers - SK biopharmaceuticals Business Division has built a business model encompassing the entire value chain from new drug R&D to marketing on the capabilities and technologies that it accumulated in the field of new drug and pharmaceutical intermediate R&D initiatives

Pipeline

Securing a competitive pipeline is paramount to success in a drug development business. To that end, we will expand our R&D programs in the CNS area, where we have already secured core capabilities. At present, we have 8 projects under clinical development and many programs in the preclinical and discovery stage.
Research Area

R&D

SK biophamaceuticals develops innovative drugs that enhance efficacy and minimize side effects in the CNS field.
Research Area
Key Technologies

Our Products